The effect of a patient informative leaflet on chronic use of proton pump inhibitors in a primary care center: a randomized control trial

dc.contributor.authorTarabay, Rami
dc.contributor.authorOsman, Mona H.
dc.contributor.authorAridi, Riwa S.
dc.contributor.authorHlais, Sani
dc.contributor.authorBeshara, Ranin Y.
dc.contributor.authorLakkis, Najla A.
dc.contributor.departmentFamily Medicine
dc.contributor.facultyFaculty of Medicine (FM)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T11:42:34Z
dc.date.available2025-01-24T11:42:34Z
dc.date.issued2022
dc.description.abstractBackground: Chronic non-medically indicated PPIs are highly prescribed worldwide. The long-term side effects of PPI must be wisely considered during an extended prescription duration. Our study purpose is to assess the impact of providing patients and physicians with educational guides on the rates of reducing or eliminating PPIs. Design and methods: A controlled study targeting adult patients with chronic PPI use was conducted in a family medicine center in Beirut. Block randomization was employed. Patients (n = 140) were equally divided into an intervention group consisting of a patient-oriented informative and motivational leaflet and a control group having the same follow-up without having the leaflet. All participants filled a questionnaire. All participants received a short phone call in 2 and 6 months. An e-mail clarifying the objective of this study was sent to all physicians and supplemented with a PPI deprescribing algorithm. Results: At the 6-month follow-up, the rate of participants who talked to treating physicians about their PPI therapy was higher in the intervention group (p-value<0.0001), and the rate of participants who stepped down or off PPI was higher in the intervention group (p-value<0.0001). In participants who stepped down or off PPI, the reported breakthrough symptoms decreased over time (moderate: 24.2%, mild: 35.5%, and nil: 40.3% at 2-month follow-up; and moderate: 0%, mild: 55.4% and nil: 44.6% at 6-month follow-up; p-value<0.0001). Conclusion: A low‐intensity, low‐cost, and easily replicable intervention encouraged a significant number of long‐term users of PPIs to reduce or stop these medications without causing significant breakthrough symptoms. © 2022 Informa UK Limited, trading as Taylor & Francis Group.
dc.identifier.doihttps://doi.org/10.1080/21548331.2022.2114743
dc.identifier.eid2-s2.0-85139375116
dc.identifier.pmid35993151
dc.identifier.urihttp://hdl.handle.net/10938/30061
dc.language.isoen
dc.publisherInforma UK Ltd
dc.relation.ispartofHospital Practice
dc.sourceScopus
dc.subjectCommunity medicine
dc.subjectDyspepsia
dc.subjectGastroenterology
dc.subjectGerd
dc.subjectPatient education
dc.subjectPrescription drug monitoring programs
dc.subjectPrimary care
dc.subjectAdult
dc.subjectHumans
dc.subjectPrimary health care
dc.subjectProton pump inhibitors
dc.subjectProton pump inhibitor
dc.subjectControlled study
dc.subjectHuman
dc.subjectRandomized controlled trial
dc.titleThe effect of a patient informative leaflet on chronic use of proton pump inhibitors in a primary care center: a randomized control trial
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2022-2056.pdf
Size:
825.44 KB
Format:
Adobe Portable Document Format

Collections